Only LIPITOR Is LIPITOR.

There Is No Generic Form of LIPITOR

Medicines can work differently in different people. So switching to a different medication may not be right for all patients. Switching from LIPITOR to generic Zocor® (simvastatin) may not lead to the same cholesterol-lowering results as with LIPITOR. While there are generic versions of other cholesterol-lowering medications, there is no approved generic form of LIPITOR currently available.

Talk to your doctor about whether LIPITOR is right for you.

LIPITOR is the #1 prescribed branded cholesterol-lowering medication in the world*

It's important to do what you can for your heart health. If you and your doctor decided on LIPITOR, it was for many good reasons.

LIPITOR is FDA-approved to significantly reduce the risk of:

  • Heart attack
  • Stroke
  • Certain kinds of heart surgeries
  • Chest pain

if you have several common risk factors, including high blood pressure, low HDL ("good" cholesterol), family history of early heart disease, smoking, and age.

LIPITOR is one of the most widely studied medicines in the world–with more than 17 years of research.

  • Over 400 ongoing or completed clinical studies—which included over 80,000 patients

LIPITOR has an established safety record.

If LIPITOR is working for you, why switch?
Before you consider switching to another medication, it's important to learn more.

If you switch, you may not get the same cholesterol-lowering results you get with LIPITOR.

  • LIPITOR is proven to lower LDL ("bad" cholesterol) 39%-60% (average effect depending on dose)
  • The cholesterol level you've achieved could change

Other things to consider:

  • Your body could respond differently to a different medication
  • You may need additional blood tests and checkups

In clinical studies, LIPITOR lowered bad cholesterol significantly more than generic Zocor (simvastatin).‡§

Before you consider switching to something other than LIPITOR, get the answers to these questions.

Zocor is a registered trademark of Merck & Co, Inc.

*IMS Health. IMS National Prescription Audit Plus™. March 2008.
Data on file. Pfizer Inc, New York, NY.
The CURVES study was conducted in 1997 to evaluate the comparative effectiveness of varying doses of LIPITOR with equivalent dose strengths of Zocor® (simvastatin), Pravachol® (pravastatin), and lovastatin over 8 weeks. The CURVES study involved 534 patients and demonstrated that LIPITOR at 10, 20, and 40 mg produced significantly greater reductions in LDL cholesterol than the milligram-equivalent of Zocor®, Pravachol®, and lovastatin.
§The CHALLENGE study was conducted to evaluate the comparative efficacy and safety of LIPITOR at 10 mg vs Zocor (simvastatin) at 20 mg and of LIPITOR at 80 mg vs Zocor at 80 mg over 6 weeks. The CHALLENGE study involved 1732 patients with high cholesterol and demonstrated that LIPITOR produced significantly greater reductions in LDL cholesterol than Zocor (simvastatin).